FLACU   $9.48  2.93% Market Closed

Frazier Lifesciences Acquisition Corp
Last Events:

2022-11-24 Signal in Stochastic changed from bearish to bearish weakening. The stochastic indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: main and signal line crossing.

2022-11-24 Signal in RSI changed from bearish recovery to bearish weakening. RSI indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: exit from the overbought zone.

2022-11-24 Trend Power changed from strong to slow.

2022-11-23 Trend pattern changed from не определен to расходящийся треугольник.

2022-11-23 Signal in Stochastic changed from не определен to bearish. The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: signal line crossed the middle level.

2022-11-23 Signal in MACD changed from не определен to bearish recovery. Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: entry into the oversold zone.

2022-11-23 Signal in RSI changed from не определен to bearish recovery. RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

2022-11-23 Signal in EMA100 changed from не определен to bearish reversal. 2022-11-16 the price crossed down the moving average line and formed a short-term downside trend.


Current temperature: 0.00
ST: 0, Cor:

Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total - Buy Sell
rsi ActivelyBuy Buy Sell
macd Buy - -
stoch Sell Buy -
ma20 - - -
ma50 - - -
ma100 - - -
ISIN KYG3710A1215
ceo Dr. James N. Topper M.D., Ph.D.
Website https://www.frazierlifesciencesacquisition.com
Frazier Lifesciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities in the biotechnology sector. The company was incorporated in 2020 and is based in Seattle, Washington.